Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only/idempotent annotations, the description discloses meaningful behaviors: graceful degradation when GLEIF/OpenFIGI is unavailable, returning figi_candidates when a name matches multiple instruments, explicitly reporting unresolved identifiers, labelling each identifier with its source, and ISIN-to-LEI mapping. None of this contradicts the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The definition is front-loaded with examples and the core 'use first' instruction, and every additional sentence provides substantive behavior. It is long and dense, making parsing harder, but for a tool with this much resolution behavior the length is largely justified.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining what is returned: CIK, ticker, company_name, LEI plus ownership, FIGI, RxCUI, ingredient, brand, and a pipeworx citation. It also covers ambiguity, unresolved identifiers, source labelling, and degradation, so an agent has enough context to invoke it correctly and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema already describes both parameters, the description adds high-value usage constraints: pass only the entity name, never the question's full noun phrase, with a concrete bond example that explains why trailing security-class words fail. It also enriches the type parameter by clarifying what each type accepts (ticker/CIK/ISIN/company name versus brand/generic drug name), going well beyond the schema's one-line enum descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The opening sentence pairs a specific verb ('resolve') with a clear resource ('user-spoken NAME to canonical/official identifiers') and precedes it with concrete query examples. The supported types section distinguishes it from generic lookup tools by listing exactly what identifiers it returns for companies and drugs.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly states 'Use FIRST whenever you have a name but need an ID,' which tells an agent when to choose this tool. It also notes that the tool replaces 2-3 manual lookups, reinforcing its role as the front-door resolver. However, it never names sibling alternatives or states when not to use it, so the guidance is strong but not exclusionary.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several groups of tools are hard to tell apart in practice: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and bet_research all route natural-language questions to similar data sources, and the polymarket_* family plus bet_research heavily overlaps. Individual descriptions are detailed, but an agent navigating this surface will frequently struggle to choose the correct entry point.

Naming Consistency3/5

The naming is readable and mostly snake_case, but conventions are mixed: some tools are verb+noun commands (resolve_entity, validate_claim), some are noun phrases (entity_profile, bet_research), and others use product prefixes inconsistently (ask_pipeworx vs pipeworx_feedback vs polymarket_edges). The polymarket_* cluster is consistent, but no clear pattern holds across the whole server.

Tool Count2/5

34 tools is past the 25-tool threshold and is especially excessive for a server named 'translate', where only three tools relate to translation. Most of the surface belongs to a broad Pipeworx data/analytics/prediction-market platform that would be better split into separate focused servers.

Completeness3/5

The Pipeworx-related workflows are fairly well-covered: lookup, grounded research, company profiling, prediction-market analysis, subscriptions, and memory all have usable tool clusters. However, the translation domain implied by the server name is thin and references a deepl_translate tool that is not actually exposed, so there is no single domain that feels fully complete.